Postprandial recruitment of neutrophils may contribute to endothelial dysfunction

Journal of Lipid Research

Volumn 44, Issue 3, 2003, Pages 576-583

  Van Oostrom, A J H H M ^a   Sijmonsma, T P ^a   Verseyden, C ^a   Jansen, E H J M ^b   De Koning, E J P ^a   Rabelink, T J ^a   Cabezas, M Castro ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Cytokines; Endothelial function; Hydroperoxides; Triglycerides

Indexed keywords

CYTOKINE; FAT; GLUCOSE; HYDROPEROXIDE; INTERLEUKIN 6; INTERLEUKIN 8; WATER; FATTY ACID; HYDROGEN PEROXIDE; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; CYTOKINE PRODUCTION; ENDOTHELIUM LESION; FAT INTAKE; GLUCOSE INTAKE; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PATHOGENESIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; VASODILATATION; ARTERIOSCLEROSIS; BIOLOGICAL MODEL; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOLOGY; PHYSIOLOGY; TIME; VASCULAR ENDOTHELIUM;

ADULT; ARTERIOSCLEROSIS; BLOOD GLUCOSE; DIETARY FATS; ENDOTHELIUM, VASCULAR; FASTING; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; INSULIN; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTE COUNT; MALE; MODELS, BIOLOGICAL; NEUTROPHILS; POSTPRANDIAL PERIOD; TIME FACTORS; TRIGLYCERIDES;

EID: 0038620491     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200419-JLR200     Document Type: Article

References (51)

1. Danesh, J., P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, J. R. Gallimore, and M. B. Pepys. 2000. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 321: 199-204.
2. Lusis, A. J. 2000. Atherosclerosis. Nature. 407: 233-241.
3. Ross, R. 1999. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340: 115-126.
4. Sullivan, G. W., I. J. Sarembock, and J. Linden. 2000. The role of inflammation in vascular diseases. J. Leukoc. Biol. 67: 591-602.
5. de Ferranti, S., and N. Rifai. 2002. C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin. Chim. Acta. 317: 1-15.
6. Ridker, P. M., N. Rifai, M. J. Stampfer, and C. H. Hennekens. 2000. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 101: 1767-1772.
7. Zozulinska, D., A. Majchrzak, M. Sobieska, K. Wiktorowicz, and B. Wierusz-Wysocka. 1999. Serum interleukin-8 level is increased in diabetic patients. Diabetologia. 42: 117-118.
8. Reape, T. J., and P. H. Groot. 1999. Chemokines and atherosclerosis. Atherosclerosis. 147: 213-225.
9. Muscari, A., G. Massarelli, L. Bastagli, G. Poggiopollini, V. Tomassetti, G. Drago, C. Martignani, P. Pacilli, P. Boni, and P. Puddu. 2000. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur. Heart J. 21: 1081-1090.
10. Witko-Sarsat, V., P. Rieu, B. Descamps-Latscha, P. Lesavre, and L. Halbwachs-Mecarelli. 2000. Neutrophils: molecules, functions and pathophysiological aspects. Lab. Invest. 80: 617-653.
11. Phillips, A. N., J. D. Neaton, D. G. Cook, R. H. Grimm, and A. G. Shaper. 1992. Leukocyte count and risk of major coronary heart disease events. Am. J. Epidemiol. 136: 59-70.
12. Huang, Z., J. Jeng, C. Wang, P. Yip, T. Wu, and T. Lee. 2001. Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis. 158: 431-436.
13. Hansen, L. K., R. H. Grimm, Jr., and J. D. Neaton. 1990. The relationship of white blood cell count to other cardiovascular risk factors. Int. J. Epidemiol. 19: 881-888.
14. Huang, Z. S., K. L. Chien, C. Y. Yang, K. S. Tsai, and C. H. Wang. 2001. Peripheral differential leukocyte counts in humans vary with hyperlipidemia, smoking, and body mass index. Lipids. 36: 237-245.
15. Schmidt, M. I., B. B. Duncan, A. R. Sharrett, G. Lindberg, P. J. Savage, S. Offenbacher, M. I. Azambuja, R. P. Tracy, and G. Heiss. 1999. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 353: 1649-1652.
16. Shurtz-Swirski, R., S. Sela, A. T. Herskovits, S. M. Shasha, G. Shapiro, L. Nasser, and B. Kristal. 2001. Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care. 24: 104-110.
17. Takeshita, S., H. Hashimoto, Y. Ono, M. Ochiai, N. Yokoyama, M. Terakura, T. Sato, and T. Isshiki. 2001. Increased leukocyte activity as a predictor for flow-limiting coronary lesions in patients with angina pectoris. Atherosclerosis. 158: 477-481.
18. Berliner, S., O. Rogowski, R. Rotstein, R. Fusman, I. Shapira, N. M. Bornstein, V. Prochorov, A. Roth, G. Keren, A. Eldor, and D. Zeltser. 2000. Activated polymorphonuclear leukocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis. Cardiology. 94: 19-25.
19. Haught, W. H., M. Mansour, R. Rothlein, T. K. Kishimoto, E. A. Mainolfi, J. B. Hendricks, C. Hendricks, and J. L. Mehta. 1996. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am. Heart J. 132: 1-8.
20. Jordan, J. E., Z. Q. Zhao, and J. Vinten-Johansen. 1999. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 43: 860-878.
21. Weitz-Schmidt, G., K. Welzenbach, V. Brinkmann, T. Kamata, J. Kallen, C. Bruns, S. Cottens, Y. Takada, and U. Hommel. 2001. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7: 687-692.
22. Braunwald, E. 1997. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med. 337: 1360-1369.
23. Superko, H. R. 1998. Did grandma give you heart disease? The new battle against coronary artery disease. Am. J. Cardiol. 82: 34Q-46Q.
24. Weintraub, M. S., I. Grosskopf, T. Rassin, H. Miller, G. Charach, H. H. Rotmensch, M. Liron, A. Rubinstein, and A. Iaina. 1996. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ. 312: 936-939.
25. Patsch, J. R., G. Miesenbock, T. Hopferwieser, V. Muhlberger, E. Knapp, J. K. Dunn, A. M. Gotto, Jr., and W. Patsch. 1992. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb. 12: 1336-1345.
26. Zilversmit, D. B. 1979. Atherogenesis: a postprandial phenomenon. Circulation. 60: 473-485.
27. The DECODE study group. European Diabetes Epidemiology Group. 1999. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet. 354: 617-621.
28. Wanten, G. J., F. P. Janssen, and A. H. Naber. 2002. Saturated triglycerides and fatty acids activate neutrophils depending on carbon chain-length. Eur. J. Clin. Invest. 32: 285-289.
29. Mohrschladt, M. F., A. W. Weverling-Rijnsburger, F. H. de Man, D. J. Stoeken, A. Sturk, A. H. Smelt, and R. G. Westendorp. 2000. Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy. Atherosclerosis. 148: 413-419.
30. Hiramatsu, K., and S. Arimori. 1988. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes. 37: 832-837.
31. Hansen, K., F. Sickelmann, R. Pietrowsky, H. L. Fehm, and J. Born. 1997. Systemic immune changes following meal intake in humans. Am. J. Physiol. 273: R548-R553.
32. Murohara, T., M. Buerke, and A. M. Lefer. 1994. Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Role of selectins. Arterioscler. Thromb. 14: 1509-1519.
33. Krebs, M., H. Stingl, P. Nowotny, D. Weghuber, M. Bischof, W. Waldhausl, and M. Roden. 2000. Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin. Chem. 46: 950-954.
34. Burstein, M., H. R. Scholnick, and R. Morfin. 1970. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11: 583-595.
35. Hijmering, M. L., E. S. Stroes, G. Pasterkamp, M. Sierevogel, J. D. Banga, and T. J. Rabelink. 2001. Variability of flow mediated dilation: consequences for clinical application. Atherosclerosis. 157: 369-373.
36. Marchesi, S., G. Lupattelli, G. Schillaci, M. Pirro, D. Siepi, A. R. Roscini, L. Pasqualini, and E. Mannarino. 2000. Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. Atherosclerosis. 153: 397-402.
37. Title, L. M., P. M. Cummings, K. Giddens, and B. A. Nassar. 2000. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J. Am. Coll. Cardiol. 36: 2185-2191.
38. Nishikawa, T., D. Edelstein, X. L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M. A. Yorek, D. Beebe, P. J. Oates, H. P. Hammes, I. Giardino, and M. Brownlee. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 404: 787-790.
39. Marfella, R., L. Quagliaro, F. Nappo, A. Ceriello, and D. Giugliano. 2001. Acute hyperglycemia induces an oxidative stress in healthy subjects. J. Clin. Invest. 108: 635-636.
40. Bae, J. H., E. Bassenge, K. B. Kim, Y. N. Kim, K. S. Kim, H. J. Lee, K. C. Moon, M. S. Lee, K. Y. Park, and M. Schwemmer. 2001. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis. 155: 517-523.
41. Dart, A. M., and J. P. Chin-Dusting, 1999. Lipids and the endothelium. Cardiovasc. Res. 43: 308-322.
42. Schratzberger, P., S. Dunzendorfer, N. Reinisch, C. M. Kahler, M. Herold, and C. J. Wiedermann. 1998. Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils. Cardiovasc. Res. 38: 516-521.
43. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55: 97-179.
44. Cassatella, M. A. 1999. Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol. 73: 369-509.
45. De Caterina, R., J. K. Liao, and P. Libby. 2000. Fatty acid modulation of endothelial activation. Am. J. Clin. Nutr. 71: 213S-223S.
46. Urakaze, M., R. Temaru, A. Satou, K. Yamazaki, T. Hamazaki, and M. Kobayashi. 1996. The IL-8 production in endothelial cells is stimulated by high glucose. Horm. Metab. Res. 28: 400-401.
47. Mohamed-Ali, V., S. Goodrick, A. Rawesh, D. R. Katz, J. M. Miles, J. S. Yudkin, S. Klein, and S. W. Coppack. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82: 4196-4200.
48. Papanicolaou, D. A., and A. N. Vgontzas. 2000. Interleukin-6: the endocrine cytokine. J. Clin. Endocrinol. Metab. 85: 1331-1333.
49. Anderson, T. J., A. Uehata, M. D. Gerhard, I. T. Meredith, S. Knab, D. Delagrange, E. H. Lieberman, P. Ganz, M. A. Creager, and A. C. Yeung. 1995. Close relation of endothelial function in the human coronary and peripheral circulations. J. Am. Coll. Cardiol. 26: 1235-1241.
50. Schroeder, S., M. D. Enderle, R. Ossen, C. Meisner, A. Baumbach, M. Pfohl, C. Herdeg, M. Oberhoff, H. U. Haering, and K. R. Karsch. 1999. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. Am. Heart J. 138: 731-739.
51. Reddy, K. G., R. N. Nair, H. M. Sheehan, and J. M. Hodgson. 1994. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J. Am. Coll. Cardiol. 23: 833-843.